NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Drug Industry Remove constraint Subjects: Drug Industry Subjects United States Remove constraint Subjects: United States

Search Results

3. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters

6. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice

9. COVID-19 public health emergency: general considerations for pre-IND meeting requests for COVID-19 related drugs and biological products : guidance for industry and investigators